Insider Trades1 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Buy | JBIO | Tom Frohlich | Chief Executive Officer | 6,000 | $7.40 | $1.3B | -25.50% | +212.74% | $44.4K | — | — | Stalk |
AI Summary
StalkJBIO remains in a Stage 2 advancing phase within its long-term uptrend, supported by Lockout Rally and Higher Highs & Higher Lows patterns. However, price is currently slipping below the short-term EMAs and the rising 50 DMA, showing sideways indecision and neutral momentum. With RSI and Options Score in mid-range and no clear exhaustion or breakout, execution readiness remains neutral, so buy-side engagement is deferred. Watch for a pullback into the EMAs or 50 DMA and subsequent acceptance before initiating new long positions.
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | Buy | JBIO | Tom Frohlich | Chief Executive Officer | 6,000 | $7.40 | $1.3B | -25.50% | +212.74% | $44.4K | — | — | Stalk |